N.Y.C., U.S.A. and London, United Kingdom-based leading clinical mental health A.I. technology company Limbic raised USD 14 million. The company announced the fundraising on March 5, 2024. Khosla Ventures led the financing for the company. Meanwhile, new investors, such as Gaingels, an LGBTQIA+/Allies investment syndicate, and Illusian, the family office of Ilkka Paananen, co-founder of Supercell, joined the round.

Purpose of financing for Limbic

The funding seeks to expand the availability of Limbic’s clinical mental health A.I. to U.S.A. health providers. 

What the company’s official has to say

Dr Ross Harper, C.E.O. and co-founder of Limbic said, “The global behavioural healthcare sector is grappling with a critical workforce supply challenge. Care providers are experiencing burnout, and services are stretched thin, operating on slim margins. Our recent funding reaffirms our commitment to scaling impactful, safe, and regulatory-compliant mental health A.I. solutions. Our A.I. was developed to enhance the capabilities of human clinicians, amplify their expertise, and extend high-quality care to meet everyone’s needs. We’ve also bolstered business outcomes for service providers and assisted in increasing workforce capacity thanks to increased operational performance.”

What the investors have to comment

Vinod Khosla of Khosla Ventures said,  “There is a grave shortage of mental healthcare providers across the globe. A.I. will allow us to realize the potential of near-free access to such care for everyone, independent of provenance and socioeconomic status. Limbic is at the forefront of this important and ambitious goal, and we are proud to partner with them.”

In addition, Gaingels’ Managing Director, Lorenzo Thione, said, “Besides the strength of its business opportunity, Limbic’s success in helping minority groups access mental healthcare played a big role in our investment in the company. Limbic’s use of artificial intelligence to increase participation in mental health services for LGBTQ+ and non-binary patients is a great example of how A.I. can measurably improve people’s lives through safe, universal and non-judgmental access.”

About the company 

The largest public healthcare system in the world has validated Limbic’s clinical mental health AI. Over 260,000 NHS patients have benefited from Limbic’s assistance in accessing care, freeing up over 50,000 clinical hours for N.H.S. services and saving up to five to ten times the economic cost for each extra user recovery.The first Generative AI companion for mental health care in the world, provided by Limbic, supports users in between therapy sessions. With the help of a sophisticated clinical artificial intelligence (A.I.) brain, a smooth chatbot interface leads patients through a selection of 100 themed activities and educational resources, offering on-demand mental health care with professional rigour.

To explore more such startups, visit Zefyron Startup Database

For more extensive analysis and Market Intelligence reports, feel free to approach us.

We try our best to fact-check and bring well-researched as well as non-plagiarized content to you. Please let us know

if there are any discrepancies in any of our published stories,

-how we can improve,

-what stories you would like us to cover

–what information you are looking for in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!

Next Article

Previous articleStormFisher raises USD 30 million investment from ARC Financial Corp
Next articleGermany-based Razor Group acquires Perch and also announces Series D financing 
Jasleen Bhatia works as a content writer for VCBay News. She is pursuing her final semester in Bachelor of Business Administration from IIPS, DAVV. Driven by her keen interest in entrepreneurship and finance, she writes business-related articles.


Please enter your comment!
Please enter your name here